Eliquis 5 mg film-coated tablets

Company
Bristol-Myers Squibb-Pfizer
Active Ingredient
Dosage Form
Film-coated tablet
Legal Category
B - prescription, may be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/11/691/006 5 milligram(s) B01AF02 Film-coated tablet
EU/1/11/691/007 5 milligram(s) B01AF02 Film-coated tablet
EU/1/11/691/008 5 milligram(s) B01AF02 Film-coated tablet
EU/1/11/691/009 5 milligram(s) B01AF02 Film-coated tablet
EU/1/11/691/010 5 milligram(s) B01AF02 Film-coated tablet
EU/1/11/691/011 5 milligram(s) B01AF02 Film-coated tablet
EU/1/11/691/012 5 milligram(s) B01AF02 Film-coated tablet
EU/1/11/691/014 5 milligram(s) B01AF02 Film-coated tablet
Licence number
EU/1/11/691/006
Strength
5 milligram(s)
ATC Code
B01AF02
Dosage Form
Film-coated tablet
Licence number
EU/1/11/691/007
Strength
5 milligram(s)
ATC Code
B01AF02
Dosage Form
Film-coated tablet
Licence number
EU/1/11/691/008
Strength
5 milligram(s)
ATC Code
B01AF02
Dosage Form
Film-coated tablet
Licence number
EU/1/11/691/009
Strength
5 milligram(s)
ATC Code
B01AF02
Dosage Form
Film-coated tablet
Licence number
EU/1/11/691/010
Strength
5 milligram(s)
ATC Code
B01AF02
Dosage Form
Film-coated tablet
Licence number
EU/1/11/691/011
Strength
5 milligram(s)
ATC Code
B01AF02
Dosage Form
Film-coated tablet
Licence number
EU/1/11/691/012
Strength
5 milligram(s)
ATC Code
B01AF02
Dosage Form
Film-coated tablet
Licence number
EU/1/11/691/014
Strength
5 milligram(s)
ATC Code
B01AF02
Dosage Form
Film-coated tablet

Bristol-Myers Squibb-Pfizer

Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, Ireland

Telephone
+3531800749749
Email
medical.information@bms.com